The profile you requested (/company/intelligent-apps) does not exist or is not published.
You are viewing a limited version of this profile. To access i3's full capabilities.
Codexis
Save
Company logo (jpg or png)
Parent company

Short description

Developer of biocatalyst technology and clean manufacturing processes

Founded in 2002
Founded in

Company type Public Public (CDXS)
Company type

Industry Group

Sector

TRL Range 7-8
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Redwood City, CA Redwood City, United States
Address
City
State
Zip
Country

Parent Companies

Traction
  • 1 M&A items
tags
Similar companies
Customers
Save
Date Company
01/25/2011

Dainippon Sumitomo Pharma (DSP) Dainippon Sumitomo Pharma (DSP)

Codexis enters Japanese market by selling its biocatalysts to DSP for use in selected undisclosed therapeutic products

Confirmed by Dainippon Sumitomo Pharma (DSP)

Partnerships
Save
Date Partner Type
12/23/2019
Roche Roche
License agreement to provide Roche with Codexis’ EvoT4TM DNA ligase high-performance molecular diagnostic enzyme.
View source    
Confirmed by Roche
Licensee
Investment Rounds
Save

IPO INFORMATION

Date

04/21/2010

IPO status

Listed

IPO Type

IPO

Amount

$78M

Initial shares

6000000

Ticker symbol

CDXS

Exchange listed

NASDAQ

Prospectus URL

Prospectus

Source URL

Source

Description

Date Investors Type Amount
06/20/2019 Casdin Capital Casdin Capital (1)
Post-money valuation of
Funding will bed used to accelerate strategic growth initiatives
PIPE $50,000,000
Click to add IPO information
Products
Save
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font